Log normal distribution of cellular uptake of radioactivity: implications for biologic responses to radiopharmaceuticals
about
Introduction to radiobiology of targeted radionuclide therapyTreatment of Radiation InjuryFlow cytometry-assisted Monte Carlo simulation predicts clonogenic survival of cell populations with lognormal distributions of radiopharmaceuticals and anticancer drugs.Monte Carlo simulation of irradiation and killing in three-dimensional cell populations with lognormal cellular uptake of radioactivity.Induction of lethal bystander effects in human breast cancer cell cultures by DNA-incorporated Iodine-125 depends on phenotype.Lognormal distribution of cellular uptake of radioactivity: statistical analysis of alpha-particle track autoradiography.Investigation of adaptive responses in bystander cells in 3D cultures containing tritium-labeled and unlabeled normal human fibroblastsEmploying a Mechanistic Model for the MAPK Pathway to Examine the Impact of Cellular all or None Behavior on Overall Tissue Response.Concomitant quantification of targeted drug delivery and biological response in individual cellsPatient exposures and consequent risks from nuclear medicine proceduresA method to predict response of cell populations to cocktails of chemotherapeutics and radiopharmaceuticals: validation with daunomycin, doxorubicin, and the alpha particle emitter (210)Po.Auger processes in the 21st century.Survival of tumor and normal cells upon targeting with electron-emitting radionuclides.Challenges and progress in predicting biological responses to incorporated radioactivityMIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy.Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy.Biological response to nonuniform distributions of (210)Po in multicellular clusters.A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy.Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia.
P2860
Q26852029-D62B95B5-9BD8-4EF1-9B44-7A41096D93C1Q27003920-3C1853FF-96C7-416A-AFE1-1CFF4A3AB1DAQ33642550-D93B2151-B625-4678-AE81-EE5C135FA213Q33642556-CF66FABF-FADA-4BA7-9E86-ACA71CE83444Q33642577-26CD46B5-0CED-43CE-B047-590BA9E2CDFBQ34024713-6F52ACBE-2DA8-4043-B884-B4D63B53B410Q34066003-E6835ABE-257E-4653-8A0B-9DD99CDB85EEQ34128970-99ED91CD-F8B6-468A-81CC-AA58DA046BA7Q34129721-249273E7-70D7-466C-BA6C-4C1CE3B64E62Q34857341-4BD13E87-7CBA-4ED0-8D72-2A013028391FQ36103417-ADCF158D-E00C-401B-924E-5B8B89A1F32EQ36282934-43CD5B97-FFA5-4D0D-8FAF-5AA7DEBA1813Q36527321-65455AD7-35EE-4494-B242-86E89938A002Q36730879-CFB865AA-37F2-4754-843E-ABCB08159DA7Q37676716-F3F83D0B-A471-4FA6-B7AE-9B523AD48984Q38724752-3644CB48-AAE5-48F6-BB6C-13022A7EADA0Q40092316-59C9BC7B-820B-46B3-8014-6A4D45CFEA3FQ42763210-2A6C5BBB-361B-46FC-8873-BC8444427001Q47607855-62EF00DB-8FFE-4460-B5FD-B1E0DC55B894
P2860
Log normal distribution of cellular uptake of radioactivity: implications for biologic responses to radiopharmaceuticals
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Log normal distribution of cel ...... ponses to radiopharmaceuticals
@en
Log normal distribution of cel ...... onses to radiopharmaceuticals.
@nl
type
label
Log normal distribution of cel ...... ponses to radiopharmaceuticals
@en
Log normal distribution of cel ...... onses to radiopharmaceuticals.
@nl
prefLabel
Log normal distribution of cel ...... ponses to radiopharmaceuticals
@en
Log normal distribution of cel ...... onses to radiopharmaceuticals.
@nl
P2860
P1476
Log normal distribution of cel ...... ponses to radiopharmaceuticals
@en
P2093
Prasad V S V Neti
Roger W Howell
P2860
P304
P407
P577
2006-06-01T00:00:00Z